Literature DB >> 18370189

Applicator and electrode design for in vivo DNA delivery by electroporation.

Dietmar Rabussay1.   

Abstract

As in vivo electroporation advances from the preclinical phase to clinical studies and eventually to routine medical practice, the design of electroporation devices becomes increasingly important. Achieving safety and efficacy levels that meet regulatory requirements, as well as user and patient friendliness, are major design considerations. In addition, the devices will have to be economical to manufacture. This chapter will focus on the design of applicators and electrodes, the pieces of hardware in direct contact with the user and the patient, and thus key elements responsible for the safety and efficacy of the procedure. The two major foreseeable applications of the technology in the DNA field are for gene therapy and DNA vaccination. Design requirements differ considerably for these applications and for the diseases to be treated or prevented. In addition to the trend of device differentiation, there is also a trend to build devices capable of performing both the step of delivering the DNA to the target tissue and the subsequent step of electroporation. This chapter presents the electrical and biological principles underlying applicator and electrode design, gives an overview of existing devices, and discusses their advantages and disadvantages. The chapter also outlines major design considerations, including regulatory pathways, and points out potential future developments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370189     DOI: 10.1007/978-1-59745-194-9_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Contactless magneto-permeabilization for intracellular plasmid DNA delivery in-vivo.

Authors:  Thomas J Kardos; Dietmar P Rabussay
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

Review 2.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

3.  Electro-gene transfer to skin using a noninvasive multielectrode array.

Authors:  Siqi Guo; Amy Donate; Gaurav Basu; Cathryn Lundberg; Loree Heller; Richard Heller
Journal:  J Control Release       Date:  2011-01-22       Impact factor: 9.776

4.  Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults.

Authors:  Mark Wallace; Barbara Evans; Sandra Woods; Robin Mogg; Lei Zhang; Adam C Finnefrock; Dietmar Rabussay; Michael Fons; John Mallee; Devan Mehrotra; Florian Schödel; Luwy Musey
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

5.  Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.

Authors:  Y Zhang; Z Qu; S Kim; V Shi; B Liao; P Kraft; R Bandaru; Y Wu; L M Greenberger; I D Horak
Journal:  Gene Ther       Date:  2010-12-23       Impact factor: 5.250

6.  Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation.

Authors:  Kate E Broderick; Amy Chan; Feng Lin; Xuefei Shen; Gleb Kichaev; Amir S Khan; Justin Aubin; Tracy S Zimmermann; Niranjan Y Sardesai
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-14       Impact factor: 10.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.